Results per Page:
At the intersection of Mpox and HIV infection: there is hope
From the HIV Outcomes, Prevention, and Epidemiology (HOPE) Group, Vaccine and Infectious Disease Division in collaboration with the Center for AIDS Research Network of Integrated Clinic Systems (CFAR CNICS)
Targeting the Integrator complex improves reactivation of HIV
From the Emerman Lab, Human Biology Division
AMP-ed on HIV prevention
From the McElrath Lab, Vaccine and Infectious Disease Division
Unveiling HIV’s immune evasion tactics by identifying mutations that escape antibody neutralization
From the Bloom Lab, Basic Sciences Division
Infectious disease scientists look beyond the pandemic
A symposium about protecting people with weakened immune systems from microbial threats
Testing cord blood transplants as a cure for leukemia — and HIV
New clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia
Wild-type vs. modification: which is better?
From Stamatatos Laboratory, Vaccine and Infectious Disease Division
25 powerful years of HIV research
Longstanding Mombasa Cohort helps answer questions about HIV risk and transmission
6 questions with Françoise Barré-Sinoussi, the woman who discovered HIV
Dr. Françoise Barré-Sinoussi on the finding that changed her life, her quest to get male scientists to believe her, the patients who moved her and the possibility of a cure
A voice for HIV cure: Scientists, activists gather for Hutch conference
Scientists, activists gather for Hutch conference on gene therapy and hope for an HIV cure
‘Angels in America’ cast visits Fred Hutch, learns about early days of AIDS
‘Angels in America’ cast visits Fred Hutch to hear about the early days of AIDS from those who were there
Hoping out loud: After years of silence, talk of an HIV cure
After years of silence, talk of an HIV cure